1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Factors associated with disease progression after discontinuation of immunotherapy for immune-related toxicity in non-small cell lung cancer
    Meeting Abstract

    Pecci, F.; Thummalapalli, R.; Alden, S.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Rizvi, H.; Wang, X.; Egger, J. V.; Vaz, V. R.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Multicenter phase II trial of LN-145 TIL cell therapy plus pembrolizumab in patients with ICI-naìˆve metastatic NSCLC
    Meeting Abstract

    Schoenfeld, A. J.; He, K.; Chesney, J.; Garon, E.; Nieva, J.; Sacher, A.; Lee, S.; Graf Finckenstein, F.; Fiaz, R.; Catlett, M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Exportin 1 inhibition constraints lineage plasticity and histological transformation through downregulation of SOX2
    Meeting Abstract

    Quintanal-Villalonga, A.; Durani, V.; Sabet, A.; Redin, E.; Kawasaki, K.; Shaffer, M.; Manoj, P.; Sridhar, H.; Haffner, M. C.; Sawyers, C. L.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Three-year outcomes with first-line pembrolizumab, in patients with non-small-cell lung cancer and a PD-L1 tumor proportion score >90%
    Meeting Abstract

    Ricciuti, B.; Arielle Elkrief, A.; Lin, J.; Altan, M.; Alessi, J.; Gandhi, M.; Pecci, F.; Lamberti, G.; Di Federico, A.; Wang, X.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Immunotherapy in the treatment of localized genitourinary cancers
    Review

    Necchi, A.; Faltas, B. M.; Slovin, S. F.; Meeks, J. J.; Pal, S. K.; Schwartz, L. H.; Huang, R. S. P.; Li, R.; Manley, B.; Chahoud, J.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Should patients with AML and active disease be transplanted?
    Meeting Abstract

    Gyurkocza, B.
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
    Journal Article

    Malki, M. M. A.; London, K.; Baez, J.; Akahoshi, Y.; Hogan, W. J.; Etra, A.; Choe, H.; Hexner, E.; Langston, A.; Abhyankar, S.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • The transplantation ecosystem: A new concept to improve access and outcomes for older allogeneic hematopoietic cell transplantation patients
    Review

    Wall, S. A.; Olin, R.; Bhatt, V.; Chhabra, S.; Munshi, P.; Hacker, E.; Hashmi, S.; Hassel, H.; Howard, D.; Jayani, R.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Estimating the lifetime medical cost burden of an allogeneic hematopoietic cell transplantation patient
    Journal Article

    Maziarz, R. T.; Devine, S.; Garrison, L. P.; Agodoa, I.; Badaracco, J.; Gitlin, M.; Perales, M. A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save